Please login to the form below

Not currently logged in
Email:
Password:

Cipla

This page shows the latest Cipla news and features for those working in and with pharma, biotech and healthcare.

Pharma must do more on antibiotic resistance, Davos meeting hears

Pharma must do more on antibiotic resistance, Davos meeting hears

although Mylan, Cipla and Fresenius Kabi are doing the best when it comes to ‘stewardship’.

Latest news

More from news
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest Intelligence

  • Deal Watch March 2017 Deal Watch March 2017

    contingent payments for the ADHD company Neurovance; Shanghai Fosun paid $90m for a majority interest in Breas (see above); Ascendis Health paid R375m ($29m) for the Southern Africa operations of Cipla ... 60. Cipla Agrimed. Ascendis Health. Acquisition.

  • Pharma deals in September 2015 Pharma deals in September 2015

    Collaboration - option to license. 555. Hetero Drugs. Cipla. Generic US based companies; InvaGen Pharmaceuticals and Exelar Pharmaceuticals.

  • Pharma deals during November 2012 Pharma deals during November 2012

    The second generics acquisition is the offer of $215m by India's Cipla for a 51 per cent stake in South Africa's third largest drug company Cipla Medpro, again driven ... 230. Cipla Medpro / Cipla. Acquisition. Generics. 215. Ensemble Therapeutics /

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Cipla names Adil Zainulbhai to board Cipla names Adil Zainulbhai to board

    He has experience at consulting firm McKinsey &Company. India-based pharma company Cipla has appointed Adil Zainulbhai to its board as an independent director. ... Zainulbhai said: "Cipla has had a huge impact in providing affordable pharmaceuticals to

  • Cipla appoints Novartis’ Subhanu Saxena as CEO Cipla appoints Novartis’ Subhanu Saxena as CEO

    Subhanu Saxena has left Novartis to join India-based generics company Cipla as its new CEO. ... Cipla's chair Dr Yusuf Hamied said: “We are delighted to have found such a good match for Cipla in Subhanu.

More from appointments
Approximately 2 fully matching, plus 0 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Dovetail

We're award-winning joint working specialists. We help our clients to transform healthcare through effective collaboration, and deliver work to feel...

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics